Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
Md. Ashadul Sk, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, B V Manjushree, S. Mounika, E Haripriya, Mayavan Viji, D Anjan
Topics & Concepts
PI3K/AKT/mTOR pathwayChemistryDocking (animal)Computational biologyPharmacologyCancer researchBiochemistrySignal transductionBiologyMedicineNursingPI3K/AKT/mTOR signaling in cancerFungal Plant Pathogen ControlSynthesis and biological activity